HRP20030458A2 - METHOD FOR THE PRODUCTION OF 4-(17α-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11?-IL)BENZALDEHYD-(1E OR 1Z)-OXIMES - Google Patents

METHOD FOR THE PRODUCTION OF 4-(17α-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11?-IL)BENZALDEHYD-(1E OR 1Z)-OXIMES Download PDF

Info

Publication number
HRP20030458A2
HRP20030458A2 HR20030458A HRP20030458A HRP20030458A2 HR P20030458 A2 HRP20030458 A2 HR P20030458A2 HR 20030458 A HR20030458 A HR 20030458A HR P20030458 A HRP20030458 A HR P20030458A HR P20030458 A2 HRP20030458 A2 HR P20030458A2
Authority
HR
Croatia
Prior art keywords
benzaldehyde
dien
oxoester
oxime
group
Prior art date
Application number
HR20030458A
Other languages
English (en)
Croatian (hr)
Inventor
Schubert Gerd
Ring Sven
Erhart Bernd
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of HRP20030458A2 publication Critical patent/HRP20030458A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Studio Devices (AREA)
HR20030458A 2000-11-10 2001-11-09 METHOD FOR THE PRODUCTION OF 4-(17α-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11?-IL)BENZALDEHYD-(1E OR 1Z)-OXIMES HRP20030458A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056676A DE10056676A1 (de) 2000-11-10 2000-11-10 Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
PCT/DE2001/004218 WO2002038582A2 (de) 2000-11-10 2001-11-09 Verfahren zur herstellung von 4-(17alpha-(substituierten-methyl)-3-oxoestra-4,9 dien-11-yl)benzaldehyd-(1e oder 1z)-oximen

Publications (1)

Publication Number Publication Date
HRP20030458A2 true HRP20030458A2 (en) 2005-04-30

Family

ID=7663441

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030458A HRP20030458A2 (en) 2000-11-10 2001-11-09 METHOD FOR THE PRODUCTION OF 4-(17α-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11?-IL)BENZALDEHYD-(1E OR 1Z)-OXIMES

Country Status (25)

Country Link
US (1) US7214808B2 (https=)
EP (1) EP1339734B1 (https=)
JP (1) JP4263478B2 (https=)
KR (1) KR100836323B1 (https=)
CN (1) CN100368427C (https=)
AT (1) ATE337328T1 (https=)
AU (2) AU2002216911B2 (https=)
BG (1) BG107886A (https=)
BR (1) BR0115249A (https=)
CA (1) CA2427632C (https=)
CZ (1) CZ301425B6 (https=)
DE (2) DE10056676A1 (https=)
EA (1) EA005530B1 (https=)
EE (1) EE200300222A (https=)
HR (1) HRP20030458A2 (https=)
HU (1) HUP0301765A2 (https=)
IL (2) IL155680A0 (https=)
MX (1) MXPA03004109A (https=)
NO (1) NO20032080D0 (https=)
NZ (1) NZ525962A (https=)
PL (1) PL205091B1 (https=)
SK (1) SK286601B6 (https=)
WO (1) WO2002038582A2 (https=)
YU (1) YU34303A (https=)
ZA (1) ZA200304480B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
JP4843372B2 (ja) * 2006-05-09 2011-12-21 株式会社リコー 画像処理装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

Also Published As

Publication number Publication date
BR0115249A (pt) 2003-08-12
KR100836323B1 (ko) 2008-06-09
AU2002216911C1 (en) 2002-05-21
NO20032080L (no) 2003-05-09
US7214808B2 (en) 2007-05-08
WO2002038582A3 (de) 2002-09-12
WO2002038582A2 (de) 2002-05-16
DE50110829D1 (de) 2006-10-05
US20040053905A1 (en) 2004-03-18
CA2427632C (en) 2010-01-26
AU1691102A (en) 2002-05-21
AU2002216911B2 (en) 2007-06-14
EA200300506A1 (ru) 2003-12-25
IL155680A (en) 2009-06-15
ZA200304480B (en) 2004-08-24
JP2004513179A (ja) 2004-04-30
CZ301425B6 (cs) 2010-02-24
NO20032080D0 (no) 2003-05-09
CZ20031282A3 (cs) 2003-08-13
PL205091B1 (pl) 2010-03-31
PL361399A1 (en) 2004-10-04
ATE337328T1 (de) 2006-09-15
EP1339734B1 (de) 2006-08-23
JP4263478B2 (ja) 2009-05-13
CN1474829A (zh) 2004-02-11
CA2427632A1 (en) 2003-05-01
HUP0301765A2 (hu) 2003-09-29
DE10056676A1 (de) 2002-05-16
EE200300222A (et) 2003-08-15
SK5512003A3 (en) 2003-10-07
SK286601B6 (sk) 2009-02-05
YU34303A (sh) 2006-08-17
CN100368427C (zh) 2008-02-13
IL155680A0 (en) 2003-11-23
KR20030081330A (ko) 2003-10-17
NZ525962A (en) 2005-02-25
BG107886A (bg) 2004-02-27
HK1063187A1 (en) 2004-12-17
EA005530B1 (ru) 2005-04-28
EP1339734A2 (de) 2003-09-03
MXPA03004109A (es) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2007258955B2 (en) Industrial process for the synthesis of 17alpha-acetoxy-11beta-[4-(N,N-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process
KR100402636B1 (ko) 17-스피로메틸렌락톤또는락톨기를갖는스테로이드
EP1242444B1 (en) Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
DK167766B1 (da) 17beta-(cyclopropyloxy(thio))-androst-5-en-3beta-ol- og -4-en-3-on-forbindelser og fremgangsmaade til deres fremstilling
HRP20030458A2 (en) METHOD FOR THE PRODUCTION OF 4-(17α-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11?-IL)BENZALDEHYD-(1E OR 1Z)-OXIMES
JPS5959700A (ja) １１β−アリ−ル−１７α−アルキニル−１７β−ヒドロキシ−４，９（１０）エストラジエン−３−オン誘導体、その製法及び該誘導体を含有する抗ゲスタゲン作用を有する製薬的調剤
US7268241B2 (en) Method for the production of 4-(17$g(a)-methyl substituted 3-oxoestra-4 9-dien-11$g(b)-yl)benzaldehyd-(1e or 1z)-oximes
JPH0776231B2 (ja) １７α―エチニル―１７β―ヒドロキシ―１８―メチル―４，１５―エストラジエン―３―オンの製法
CA1122591A (en) .delta. sun15 xx-steroid
HK1063187B (en) PROCESS FOR THE PRODUCTION OF 4-(17α-SUBSTITUTED-3-OXOESTRA-4, 9-DIEN-11β-YL)BENZALDEHYDE-(1E OR 1Z)-OXIMES
WO2007118711A1 (en) 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

ODBC Application rejected